Sun Pharmaceutical Industries informs about approval for NDA

21 Dec 2018 Evaluate

Sun Pharmaceutical Industries has informed that the U.S. Food and Drug Administration (USFDA) has granted approval for the New Drug Application (NDA), to a wholly owned subsidiary of the company, for ElepsiaTM XR 1000 mg (levetiracetam 1000 mg) and ElepsiaTM XR 1500 mg (levetiracetam 1500 mg). This product was filed from the company’s  Halol (Gujarat, India) facility. The company’s wholly owned subsidiary had in-licensed ELEPSIATM XR from Sun Pharma Advanced Research Company  (SPARC) in July 2016.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×